Correlation Between Edgewise Therapeutics and Phreesia

Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Phreesia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Phreesia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edgewise Therapeutics and Phreesia, you can compare the effects of market volatilities on Edgewise Therapeutics and Phreesia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Phreesia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Phreesia.

Diversification Opportunities for Edgewise Therapeutics and Phreesia

-0.11

Correlation Coefficient

Edgewise Therapeutics  Phreesia

Good diversification

The 3 months correlation between Edgewise and Phreesia is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Phreesia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phreesia and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Phreesia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phreesia has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Phreesia go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Phreesia

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Phreesia. In addition to that, Edgewise Therapeutics is 1.12 times more volatile than Phreesia. It trades about -0.05 of its total potential returns per unit of risk. Phreesia is currently generating about 0.02 per unit of volatility. If you would invest  2,573  in Phreesia on December 29, 2024 and sell it today you would earn a total of  27.00  from holding Phreesia or generate 1.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Edgewise Therapeutics  vs.  Phreesia

Edgewise Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Edgewise Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Phreesia

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Phreesia are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical indicators, Phreesia is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Edgewise Therapeutics and Phreesia

The main advantage of trading using opposite Edgewise Therapeutics and Phreesia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Phreesia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phreesia will offset losses from the drop in Phreesia's long position.

The idea behind Edgewise Therapeutics and Phreesia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.